Literature DB >> 290744

Plasma amino acids in hepatic encephalopathy.

P Ferenci, F Wewalka.   

Abstract

In 75 cases of histologically verified liver cirrhosis the plasma amino acids were determined by ion exchange chromatography and the results were correlated with different liver function tests as prothrombin time, pseudocholinesterase, serum albumin, GOT, bilirubin and venous ammonia. Out of these parameters prothrombin time, pseudocholinesterase and serum albumin significantly correlated with the sum of branched-chain amino acids and with the Fischer's quotient (molar ratio of branched-chain and aromatic amino acids). Methionin and aromatic amino acids inversely correlated with these parameters, additionally methionin positively correlated with bilirubin and GOT. By comparing plasma amino acid levels in cirrhotics without and with hepatic encephalopathy (grade 3 or 4) no significant differences were found. "Fischer's quotient" showed an overlap in patients with and without encephalopathy. Therefore the precipitation of hepatic encephalopathy is not fully explained by the changes in plasma amino acids. Therapeutic administrations of specially mixtures of amino acids with a high content in branched-chain and a low content in aromatic amino acids correct the plasma amino inbalance for a short time and improves hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 290744

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  5 in total

1.  Characteristic metabolism of free amino acids in cetacean plasma: cluster analysis and comparison with mice.

Authors:  Kazuki Miyaji; Kenji Nagao; Makoto Bannai; Hiroshi Asakawa; Kaoru Kohyama; Dai Ohtsu; Fumio Terasawa; Shu Ito; Hajime Iwao; Nobuyo Ohtani; Mitsuaki Ohta
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

2.  Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.

Authors:  Tadakazu Hisamatsu; Susumu Okamoto; Masaki Hashimoto; Takahiko Muramatsu; Ayatoshi Andou; Michihide Uo; Mina T Kitazume; Katsuyoshi Matsuoka; Tomoharu Yajima; Nagamu Inoue; Takanori Kanai; Haruhiko Ogata; Yasushi Iwao; Minoru Yamakado; Ryosei Sakai; Nobukazu Ono; Toshihiko Ando; Manabu Suzuki; Toshifumi Hibi
Journal:  PLoS One       Date:  2012-01-31       Impact factor: 3.240

3.  Multi-layered network structure of amino acid (AA) metabolism characterized by each essential AA-deficient condition.

Authors:  N Shikata; Y Maki; Y Noguchi; M Mori; T Hanai; M Takahashi; M Okamoto
Journal:  Amino Acids       Date:  2006-10-13       Impact factor: 3.520

4.  Current trends in the treatment of hepatic encephalopathy.

Authors:  Mohamad Rasm Al Sibae; Brendan M McGuire
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

5.  Branched-chain amino acids inhibit the TGF-beta-induced down-regulation of taurine biosynthetic enzyme cysteine dioxygenase in HepG2 cells.

Authors:  Asami Hagiwara; Sonoko Ishizaki; Kenji Takehana; Shoji Fujitani; Ichiro Sonaka; Hideo Satsu; Makoto Shimizu
Journal:  Amino Acids       Date:  2014-02-20       Impact factor: 3.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.